XML 39 R11.htm IDEA: XBRL DOCUMENT
v3.24.3

Marketable securities | 9 Months Ended
--- | ---
Sep. 30, 2024
Marketable securities [Abstract] |
Marketable securities |
6. | Marketable securities
|  | Marketable securities |
|  | $’000 |
Fair value |  |  |  |
At January 1, 2024 |  |  | 88,667 |
Accrued interest |  |  | 2,878 |
Interest received |  |  | (801 | )
Redemptions and disposals of marketable securities |  |  | (19,780 | )
Revaluation adjustment |  |  | 303 |
At September 30, 2024 |  |  | 71,267 |
The Group holds government and corporate listed bonds which comprise marketable securities measured at FVOCI. These marketable securities had a fair value of $71.3 million at September 30, 2024 (December 31, 2023: $88.7 million). During the nine month period ended September 30, 2024, a number of marketable securities were redeemed. This resulted in total proceeds of $19.8 million in the period, which includes accrued interest. The impairment loss allowance for expected credit losses at the reporting date was $0.1 million (December 31, 2023: $0.1 million). At September 30, 2024, the maturity of the Group’s marketable securities ranges from one month to three years. This maturity has been reflected in the allocation of current and non-current assets in the unaudited condensed consolidated interim statement of financial position. The movement through OCI for the three and nine months ended September 30, 2024, is shown in the table below as follows:
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
|  | $’000 |  |  | $’000 |  |  | $’000 |  |  | $’000 |
Revaluation adjustments |  |  | 906 |  |  |  | (445 | ) |  |  | 303 |  |  |  | (1,215 | )
Movement of expected credit losses on assets measured at FVOCI |  |  | 2 |  |  |  | 17 |  |  |  | (45 | ) |  |  | (1 | )
Movement on marketable securities through OCI |  |  | 908 |  |  |  | (428 | ) |  |  | 258 |  |  |  | (1,216 | )

X
- References No definition available. + Details
Name: | ghrs_SecuritiesMarketableAbstract
Namespace Prefix: | ghrs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration